公开(公告)号：US20180027843A1

公开(公告)日：2018-02-01

申请号：US15547229

申请日：2016-01-28

申请人： Korea Research Institute of Bioscience and Biotechnology

发明人： Woo Song Lee ,  Hyung Jae Jeong ,  Mun Chual Rho ,  Young Bae Ryu ,  Hyung Jun Kwon ,  Su Jin Park ,  Ji Young Park

IPC分类号： A23K20/10

CPC分类号： A23K20/10 ,  A23K10/26 ,  A23K10/30 ,  A23K20/158 ,  A23K50/00 ,  A23K50/48

摘要： The present invention relates to a composition for removing an amine-based compound, comprising an oleoresin turmeric extract, a fraction thereof, or water-soluble curcumin, a licorice extract or a fraction thereof, and a salmon milt extract as an active ingredient; and a composition for feed and feed additive comprising the same. The composition of the present invention can reduce an amine-based compound such as ammonia in animal excrement that causes the odor, and thereby reduce the odor caused by the amine-based compound and provide an effect of improving a feeding environment.

公开(公告)号：US20230190856A1

公开(公告)日：2023-06-22

申请号：US18067805

申请日：2022-12-19

申请人： KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY ,  BIOTEN CO., LTD

发明人： Woo Song LEE ,  Hyung-Jun Kwon ,  Woo Sik Kim ,  Young Bae Ryu ,  In Chul Lee ,  Hyung Jae Jeong ,  Ji Young Park

IPC分类号： A61K36/9066 ,  A61K36/28 ,  A61K36/484 ,  A61P31/14 ,  A61K9/00

CPC分类号： A61K36/9066 ,  A61K36/28 ,  A61K36/484 ,  A61P31/14 ,  A61K9/0056

摘要： The present disclosure relates to a composition comprising a complex that includes a curcuminoid-based compound and a steviol glycoside, or a curcuminoid-based compound and a licorice extract or a fraction thereof; and a use of the composition for enhancement of immunity according to an enhancement of activity or a cell number of immune cells and/or a use of the composition for prevention, improvement, or treatment of COVID-19.
The complex including curcumin and a steviol glycoside, or a licorice extract or a fraction thereof according to the present disclosure, which are food materials that have been registered with the Ministry of Food and Drug Safety and have received the Generally Recognized as Safe (GRAS) rating from the U.S. FDA, and whose safety has already been confirmed, inhibits symptoms of COVID-19 by activating Th1 cells, CD8 T cells, and NK cells. Therefore, the complex can be provided as a food and pharmaceutical composition for preventing, improving, or treating COVID-19.